GLP-1 / metabolic
Adipotide
Preclinical (animal)FTPP / prohibitin-targeting peptide · Pro-apoptotic targeting peptide
Experimental peptide that kills fat-tissue blood supply; animal-only.
What it is
A synthetic peptide combining a prohibitin-homing sequence with a pro-apoptotic domain, designed to destroy the vasculature feeding white fat.
How it works
Homes to prohibitin on fat-tissue blood-vessel endothelium and triggers apoptosis, cutting off the adipose blood supply.
Studied for
Obesity (dramatic weight loss in obese mice and monkeys).
Regulatory status
Not approved; research chemical.
Safety
Animal studies showed dose-dependent kidney toxicity; human safety essentially unknown — not for human use.
What the community reports about Adipotide
Aggregated from real community discussions across social platforms and forums. Anecdotal and self-reported — not causal, not medical advice.
The fat-cell-vasculature-killing chimeric peptide — designed in mouse models to selectively destroy blood vessels supplying white adipose tissue, but never approved, with serious cytotoxicity concerns; placed in F-Tier alongside Dihexa in corpus tier list.
Aggregated from public discussions and community forums, synthesized into themes and counts. Anecdotal and self-reported — not causal, not evidence a compound is safe or effective, not medical advice, and not a recommendation to use. No dosing shown.
Educational information only — not medical advice, and not a recommendation to use any compound. Many peptides here are not approved for human use; legal status and evidence quality vary and are noted above. This page contains no dosing information. Consult a qualified clinician before making any health decision.